HEMGENIX SECRETS

Quantity of eligible individuals: CDEC talked about the uncertainty in the amount of sufferers with moderately extreme to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some sufferers who're classified as having mild or reasonable ailment could possibly have a sign